Αρχική World News Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised... World News Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised Pancreatic Adenocarcinoma Following Preoperative (m)FOLFIRINOX Από Ogkologos - 11 Μαρτίου, 2025 938 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a retrospective cohort study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Cancer Prevention and Screening Account for Most Cancer Deaths Averted Among... 3 Φεβρουαρίου, 2025 Re-Thinking Community 10 Δεκεμβρίου, 2021 Can Acupuncture Help Cancer Survivors with Chronic Pain? 22 Απριλίου, 2021 Adjuvant Pembrolizumab Improves Overall Survival Among Patients with Clear-Cell Renal Cell... 24 Απριλίου, 2024 Φόρτωση περισσοτέρων HOT NEWS Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for... Five Questions With…Francisco. Metastatic Breast Cancer: New ESMO Guideline With Evidence-Based Recommendations [ESMO Press... Off Target: Investigating the Abscopal Effect as a Treatment for Cancer